Thus, studies show that visfatin activates the AKT serine/threonine kinase/phosphoinositide 3‐kinase (AKT/PI3K) and extracellular signal‐regulated kinase/mitogen‐activated protein kinase (ERK/MAPK) pathways, leading to the proliferation of BC cells.28 Here, MARK2 is linked to breast cancer.